10.1136/oemed-2019-106108 52 HarrisonM
Revs up overnight metabolism to burn fat as you rest
#CiplaAt90 #CaringforLife Cipla has the rights to distribute and promote Yurpeak, a prescription based the first and only dual agonist of glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors, indicated as an adjunct to diet and exercise for the treatment of type 2 diabetes and chronic weight management in adults with obesity (BMI 30) or overweight (BMI 27) with at least one weight-related comorbidity
Thnh phn: 1500mg L-glutathione, axit alpha lipoic, silymarin, L-cysteine, chit xut tr xanh
Warning: Once opened, keep refrigerated and consume within 24 hours
233 These devices measure various respiratory parameters at one or more points of contact such as the fingertip, chin, or chest